Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 733

1.

Group metacognitive therapy for repetitive negative thinking in primary and non-primary generalized anxiety disorder: An effectiveness trial.

McEvoy PM, Erceg-Hurn DM, Anderson RA, Campbell BN, Swan A, Saulsman LM, Summers M, Nathan PR.

J Affect Disord. 2014 Dec 29;175C:124-132. doi: 10.1016/j.jad.2014.12.046. [Epub ahead of print]

PMID:
25601312
[PubMed - as supplied by publisher]
2.

Identifying Predictors of Longitudinal Decline in the Level of Medical Care Received by Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Casillas J, Oeffinger KC, Hudson MM, Greenberg ML, Yeazel MW, Ness KK, Henderson TO, Robison LL, Armstrong GT, Liu Q, Leisenring W, Yasui Y, Nathan PC.

Health Serv Res. 2015 Jan 20. doi: 10.1111/1475-6773.12282. [Epub ahead of print]

PMID:
25600956
[PubMed - as supplied by publisher]
3.

Effects of Oxytocin on Attention to Emotional Faces in Healthy Volunteers and Highly Socially Anxious Males.

Clark-Elford R, Nathan PJ, Auyeung B, Mogg K, Bradley BP, Sule A, Müller U, Dudas RB, Sahakian BJ, Baron-Cohen S.

Int J Neuropsychopharmacol. 2014 Oct 31. pii: pyu012. doi: 10.1093/ijnp/pyu012. [Epub ahead of print]

PMID:
25552432
[PubMed - as supplied by publisher]
4.

Age-Dependent Changes in Health Status in the Childhood Cancer Survivor Cohort.

Hudson MM, Oeffinger KC, Jones K, Brinkman TM, Krull KR, Mulrooney DA, Mertens A, Castellino SM, Casillas J, Gurney JG, Nathan PC, Leisenring W, Robison LL, Ness KK.

J Clin Oncol. 2014 Dec 29. pii: JCO.2014.57.4863. [Epub ahead of print]

PMID:
25547510
[PubMed - as supplied by publisher]
5.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R, Grange F, Mortier L, Chiarion-Sileni V, Drucis K, Krajsova I, Hauschild A, Lorigan P, Wolter P, Long GV, Flaherty K, Nathan P, Ribas A, Martin AM, Sun P, Crist W, Legos J, Rubin SD, Little SM, Schadendorf D.

N Engl J Med. 2015 Jan 1;372(1):30-9. doi: 10.1056/NEJMoa1412690. Epub 2014 Nov 16.

PMID:
25399551
[PubMed - indexed for MEDLINE]
6.

The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.

Baxter NN, Daly C, Gupta S, Pole JD, Sutradhar R, Greenberg ML, Nathan PC.

BMC Cancer. 2014 Nov 3;14:805. doi: 10.1186/1471-2407-14-805.

PMID:
25367402
[PubMed - in process]
Free PMC Article
7.

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.

Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Casey M, Ouellet D, Martin AM, Le N, Patel K, Flaherty K.

N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29.

PMID:
25265492
[PubMed - indexed for MEDLINE]
8.

Role of the MEK inhibitor trametinib in the treatment of metastatic melanoma.

King JW, Nathan PD.

Future Oncol. 2014;10(9):1559-70. doi: 10.2217/fon.14.89.

PMID:
25145427
[PubMed - in process]
9.

A primary care audit of familial risk in patients with a personal history of breast cancer.

Nathan P, Ahluwalia A, Chorley W.

Fam Cancer. 2014 Dec;13(4):591-4. doi: 10.1007/s10689-014-9737-0.

PMID:
25096803
[PubMed - in process]
10.

NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.

Chen JL, Dawoodji A, Tarlton A, Gnjatic S, Tajar A, Karydis I, Browning J, Pratap S, Verfaille C, Venhaus RR, Pan L, Altman DG, Cebon JS, Old LL, Nathan P, Ottensmeier C, Middleton M, Cerundolo V.

Int J Cancer. 2015 Mar 15;136(6):E590-601. doi: 10.1002/ijc.29118. Epub 2014 Aug 14.

PMID:
25081390
[PubMed - in process]
11.

Interpersonal problems across restrictive and binge-purge samples: data from a community-based eating disorders clinic.

Raykos BC, McEvoy PM, Carter O, Fursland A, Nathan P.

Eat Behav. 2014 Aug;15(3):449-52. doi: 10.1016/j.eatbeh.2014.06.008. Epub 2014 Jun 21.

PMID:
25064298
[PubMed - in process]
12.

The development of scales to measure childhood cancer survivors' readiness for transition to long-term follow-up care as adults.

Klassen AF, Rosenberg-Yunger ZR, D'Agostino NM, Cano SJ, Barr R, Syed I, Granek L, Greenberg ML, Dix D, Nathan PC.

Health Expect. 2014 Jul 22. doi: 10.1111/hex.12241. [Epub ahead of print]

PMID:
25052198
[PubMed - as supplied by publisher]
13.

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries.

Porta C, Levy A, Hawkins R, Castellano D, Bellmunt J, Nathan P, McDermott R, Wagstaff J, Donnellan P, McCaffrey J, Vekeman F, Neary MP, Diaz J, Mehmud F, Duh MS.

Cancer Med. 2014 Dec;3(6):1517-26. doi: 10.1002/cam4.302. Epub 2014 Jul 18.

PMID:
25045157
[PubMed - in process]
Free PMC Article
14.

Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia.

Ness KK, Kaste SC, Zhu L, Pui CH, Jeha S, Nathan PC, Inaba H, Wasilewski-Masker K, Shah D, Wells RJ, Karlage RE, Robison LL, Cox CL.

Leuk Lymphoma. 2014 Aug 20:1-8. [Epub ahead of print]

PMID:
25030039
[PubMed - as supplied by publisher]
15.

Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder.

Gorka SM, Fitzgerald DA, Labuschagne I, Hosanagar A, Wood AG, Nathan PJ, Phan KL.

Neuropsychopharmacology. 2015 Jan;40(2):278-86. doi: 10.1038/npp.2014.168. Epub 2014 Jul 7.

PMID:
24998619
[PubMed - in process]
16.

Factors associated with recruiting adult survivors of childhood cancer into clinic-based research.

Mertens AC, Liu W, Ness KK, McDonald A, Hudson MM, Wasilewski-Masker K, Bhatia S, Nathan PC, Leonard M, Srivastava K, Robison LL, Green DM.

Pediatr Blood Cancer. 2014 Oct;61(10):1846-51. doi: 10.1002/pbc.25130. Epub 2014 Jun 29.

PMID:
24976622
[PubMed - indexed for MEDLINE]
17.

The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.

Kelly E, Mundell SJ, Sava A, Roth AL, Felici A, Maltby K, Nathan PJ, Bullmore ET, Henderson G.

Psychopharmacology (Berl). 2015 Jan;232(1):305-14. doi: 10.1007/s00213-014-3666-3. Epub 2014 Jun 29.

PMID:
24973897
[PubMed - in process]
Free PMC Article
18.

Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC.

Lancet Oncol. 2014 Jul;15(8):841-51. doi: 10.1016/S1470-2045(14)70265-7. Epub 2014 Jun 19.

PMID:
24954778
[PubMed - indexed for MEDLINE]
19.

Effects of the KIBRA Single Nucleotide Polymorphism on Synaptic Plasticity and Memory: A Review of the Literature.

Schwab LC, Luo V, Clarke CL, Nathan PJ.

Curr Neuropharmacol. 2014 May;12(3):281-8. doi: 10.2174/1570159X11666140104001553.

PMID:
24851092
[PubMed]
Free PMC Article
20.

Decline in physical activity level in the Childhood Cancer Survivor Study cohort.

Wilson CL, Stratton K, Leisenring WL, Oeffinger KC, Nathan PC, Wasilewski-Masker K, Hudson MM, Castellino SM, Stovall M, Armstrong GT, Brinkman TM, Krull KR, Robison LL, Ness KK.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1619-27. doi: 10.1158/1055-9965.EPI-14-0213. Epub 2014 May 19.

PMID:
24842624
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk